Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia: a systematic review and network Meta-analysis

Stefano Molica; Diana Giannarelli; Tait D. Shanafelt

doi:10.1080/10428194.2019.1691193

Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia: a systematic review and network Meta-analysis

Stefano Molica, Diana Giannarelli, Tait D. Shanafelt

Istituto Regina Elena

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Leukemia and Lymphoma
DOIs	https://doi.org/10.1080/10428194.2019.1691193
Publication status	Accepted/In press - Jan 1 2019

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2019.1691193

Cite this

@article{4d8de98c4212435e9faa72789083de61,

title = "Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia: a systematic review and network Meta-analysis",

author = "Stefano Molica and Diana Giannarelli and Shanafelt, {Tait D.}",

year = "2019",

month = jan,

day = "1",

doi = "10.1080/10428194.2019.1691193",

language = "English",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia

T2 - a systematic review and network Meta-analysis

AU - Molica, Stefano

AU - Giannarelli, Diana

AU - Shanafelt, Tait D.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85075240011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075240011&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1691193

DO - 10.1080/10428194.2019.1691193

M3 - Letter

C2 - 31724894

AN - SCOPUS:85075240011

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

ER -

Comparison of venetoclax plus rituximab with B-cell receptor inhibitors in patients with relapsed/refractory chronic lymphocytic leukemia: a systematic review and network Meta-analysis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this